Sumatriptan is able to improve symptoms of early satiety in dyspeptic patie
nts by relaxing the gastric fundus. The aim of this study was to verify the
efficacy of intranasal administration of sumatriptan on gastric sensory mo
tor function, in order to provide a new pharmacotherapeutic approach to fun
ctional dyspepsia. Thirteen healthy subjects were investigated twice on sep
arate days. A gastric barostat was used to study the effect of placebo and
sumatriptan, 20 mg intranasally, on basal fundic tone. In addition, stepwis
e isobaric distensions were performed and perception was measured before an
d after administration of drugs. Placebo had no effect on gastric tone and
on perception. Sumatriptan caused a small, but short-lasting gastric relaxa
tion and had no significant effect on sensitivity to distension and gastric
compliance. Unlike the subcutaneous formulation, the intranasal administra
tion of sumatriptan had no effect on gastric sensory motor functions, and t
his probably reflects a low biovailability of intranasally administered sum
atriptan.